SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CHOW HERBERT S.

(Last)

(First)

(Middle)

C/O STELLAR BIOTECHNOLOGIES, INC.

332 EAST SCOTT STREET

(Street)

PORT HUENEME

93041

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/01/2014

3. Issuer Name and Ticker or Trading Symbol
Stellar Biotechnologies, Inc. [ SBOTF ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Technology Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares, without par value⁽¹⁾	561,767	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)⁽¹⁾	⁽²⁾	05/17/2017	Common Shares	55,000	$0.2402⁽³⁾	D
Stock Option (Right to Buy)⁽¹⁾	⁽⁴⁾	08/08/2018	Common Shares	75,000	$0.6594⁽⁵⁾	D
Stock Option (Right to Buy)⁽¹⁾	⁽⁶⁾	04/13/2019	Common Shares	75,000	$0.4222⁽⁷⁾	D
Stock Option (Right to Buy)⁽¹⁾	⁽⁸⁾	08/09/2019	Common Shares	75,000	$0.3719⁽⁹⁾	D
Stock Option (Right to Buy)⁽¹⁾	⁽¹⁰⁾	12/19/2019	Common Shares	57,500	$0.2535⁽¹¹⁾	D
Stock Option (Right to Buy)⁽¹⁾	⁽¹²⁾	05/23/2020	Common Shares	100,000	$0.5589⁽¹³⁾	D
Stock Option (Right to Buy)⁽¹⁾	⁽¹⁴⁾	11/01/2020	Common Shares	100,000	$1.83	D
Warrants⁽¹⁾	01/02/2013	01/04/2016	Common Shares	38,400	$0.4025⁽¹⁵⁾	D

Explanation of Responses:

1. This Form 3 is being filed as the result of the determination by the Issuer that, in accordance with Rule 3b-4 under the Securities Exchange Act of 1934, as amended (the "Act"), it is no longer a foreign private issuer and is now subject to the reporting requirements of the Act and the rules thereunder applicable to a U.S. domestic issuer.

2. The option was granted on May 18, 2010, is fully vested and immediately exercisable.

3. The options are exercisable at a price of C$0.25. The US dollar price reported on this Form 3 in column 4 reflects the US dollar equivalent exercise price on the grant date, calculated at the closing price for cable transfers in Canadian dollars as reported by Yahoo Finance on such date of U.S.$1.00 = CDN$1.0407.

4. The option was granted on August 8, 2011, is fully vested and immediately exercisable.

5. The options are exercisable at a price of C$0.65. The US dollar price reported on this Form 3 in column 4 reflects the US dollar equivalent exercise price on the grant date, calculated at the closing price for cable transfers in Canadian dollars as reported by Yahoo Finance on such date of U.S.$1.00 = CDN$0.9857.

6. The option was granted on April 13, 2012, is fully vested and immediately exercisable.

7. The options are exercisable at a price of C$0.42. The US dollar price reported on this Form 3 in column 4 reflects the US dollar equivalent exercise price on the grant date, calculated at the closing price for cable transfers in Canadian dollars as reported by Yahoo Finance on such date of U.S.$1.00 = CDN$0.9947.

8. The option was granted on August 9, 2012, is fully vested and immediately exercisable.

9. The options are exercisable at a price of C$0.37. The US dollar price reported on this Form 3 in column 4 reflects the US dollar equivalent exercise price on the grant date, calculated at the closing price for cable transfers in Canadian dollars as reported by Yahoo Finance on such date of U.S.$1.00 = CDN$0.995.

10. The option was granted on December 19, 2012, is fully vested and immediately exercisable.

11. The options are exercisable at a price of C$0.25. The US dollar price reported on this Form 3 in column 4 reflects the US dollar equivalent exercise price on the grant date, calculated at the closing price for cable transfers in Canadian dollars as reported by Yahoo Finance on such date of U.S.$1.00 = CDN$0.986.

12. One-third of the option vested immediately, one-third of the option vested on the first anniversary of May 23, 2013, and one-third vests 18 months after May 23, 2013.

13. The options are exercisable at a price of C$0.58. The US dollar price reported on this Form 3 in column 4 reflects the US dollar equivalent exercise price on the grant date, calculated at the closing price for cable transfers in Canadian dollars as reported by Yahoo Finance on such date of U.S.$1.00 = CDN$1.0377.

14. One-third of the option vested immediately, one-third of the option vested on the first anniversary of November 1, 2013, and one-third vests 18 months after November 1, 2013.

15. The warrants are exercisable at a price of C$0.40. The US dollar price reported on this Form 3 in column 4 reflects the US dollar equivalent exercise price on the grant date, calculated at the closing price for cable transfers in Canadian dollars as reported by Yahoo Finance on such date of U.S.$1.00 = CDN$0.9939.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kathi Niffenegger, as Attorney in Fact	09/24/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.